.show-script { display: block; } .hide-script { display: none; }

Enable Javascript to enjoy full feature!

2 days ago

Eli Lilly (LLY) Stock: Pharmaceutical Giant Acquires Ajax Therapeutics in $2.3B Blood Cancer Deal

Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood cancers to its pipeline.

The post Eli Lilly (LLY) Stock: Pharmaceutical Giant Acquires Ajax Therapeutics in $2.3B Blood Cancer Deal appeared first on Blockonomi.

Source: Blockonomi →

Related News